Trial Profile
An Open-Label, Multi-Center, Extension Study to Evaluate the Safety and Tolerability of Peginesatide for the Long-Term Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease [Extension of 700245063]
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 27 May 2014
Price :
$35
*
At a glance
- Drugs Peginesatide (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Affymax
- 27 May 2014 New trial record